These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1437655)

  • 21. The effects of ellagic acid and 13-cis-retinoic acid on N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats.
    Daniel EM; Stoner GD
    Cancer Lett; 1991 Feb; 56(2):117-24. PubMed ID: 1998940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat.
    Celik G; Semiz A; Karakurt S; Arslan S; Adali O; Sen A
    Biomed Res Int; 2013; 2013():358945. PubMed ID: 23971029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
    Mady FM; Ibrahim SR
    Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of ellagic acid O-alkyl derivatives and isolation of ellagic acid as a tetrahexanoyl derivative from Fragaria ananassa.
    Heur YH; Zeng W; Stoner GD; Nemeth GA; Hilton B
    J Nat Prod; 1992 Oct; 55(10):1402-7. PubMed ID: 1453178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers.
    Ceci C; Graziani G; Faraoni I; Cacciotti I
    Nanotechnology; 2020 Sep; 31(38):382001. PubMed ID: 32380485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action.
    Teel RW
    Cancer Lett; 1986 Mar; 30(3):329-36. PubMed ID: 3697951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ellagic acid metabolism and binding to DNA in organ explant cultures of the rat.
    Teel RW; Martin RM; Allahyari R
    Cancer Lett; 1987 Aug; 36(2):203-11. PubMed ID: 3621152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ellagic acid-borax fluorescence interaction: application for novel cyclodextrin-borax nanosensors for analyzing ellagic acid in food samples.
    Matencio A; Navarro-Orcajada S; García-Carmona F; López-Nicolás JM
    Food Funct; 2018 Jul; 9(7):3683-3687. PubMed ID: 29957817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods.
    Garcia-Muñoz C; Vaillant F
    Crit Rev Food Sci Nutr; 2014; 54(12):1584-98. PubMed ID: 24580560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
    Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
    Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ellagic acid embryoprotection in vitro: distribution and effects on DNA adduct formation.
    Frank AA; Collier JM; Forsyth CS; Zeng W; Stoner GD
    Teratology; 1993 Apr; 47(4):275-80. PubMed ID: 8322221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene.
    Barch DH; Rundhaugen LM; Pillay NS
    Carcinogenesis; 1995 Mar; 16(3):665-8. PubMed ID: 7697830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro.
    Constantinou A; Stoner GD; Mehta R; Rao K; Runyan C; Moon R
    Nutr Cancer; 1995; 23(2):121-30. PubMed ID: 7644381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional chemoprevention of carcinogen-induced tumors in rat colon.
    Liu T; Mokuolu AO; Rao CV; Reddy BS; Holt PR
    Gastroenterology; 1995 Oct; 109(4):1167-72. PubMed ID: 7557082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD(P)H:quinone reductase gene.
    Barch DH; Rundhaugen LM
    Carcinogenesis; 1994 Sep; 15(9):2065-8. PubMed ID: 7522986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary carcinogenesis and its prevention by dietary polyphenolic compounds.
    Castonguay A
    Ann N Y Acad Sci; 1993 May; 686():177-85. PubMed ID: 8512246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.
    Seeram NP; Lee R; Heber D
    Clin Chim Acta; 2004 Oct; 348(1-2):63-8. PubMed ID: 15369737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beware of pomegranates bearing 40% ellagic Acid.
    Lansky EP
    J Med Food; 2006; 9(1):119-22. PubMed ID: 16579739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of digestive gland cells of freshwater mussel Unio tumidus to phenolic compound exposure in vivo.
    Labieniec M; Biernat M; Gabryelak T
    Cell Biol Int; 2007 Jul; 31(7):683-90. PubMed ID: 17314053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products.
    Dionisio KL; Phillips K; Price PS; Grulke CM; Williams A; Biryol D; Hong T; Isaacs KK
    Sci Data; 2018 Jul; 5():180125. PubMed ID: 29989593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.